Pricing Log in Create free account

Avalo Therapeutics, Inc. (AVTX) vs BlossomHill Therapeutics, Inc. (BLSM)

Avalo Therapeutics, Inc. and BlossomHill Therapeutics, Inc. are both Biotechnology companies. Avalo Therapeutics, Inc. and BlossomHill Therapeutics, Inc. are of similar size ($394.5M and $388.8M). Across the 9 metrics below, Avalo Therapeutics, Inc. leads on 6 and BlossomHill Therapeutics, Inc. on 3.

Valuation

Metric AVTX BLSM Biotechnology median
P/E n/m n/m 10.64
P/S 254.55 n/m 9.59
P/B 0.71 n/m 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA 0.78 0.86 0.65
EV/Sales (57.24) n/m 9.45
Earnings yield (65.26%) (215.71%) (34.69%)
Free cash flow yield (43.84%) (193.74%) (24.02%)

Profitability

Metric AVTX BLSM Biotechnology median
Gross margin 64.72% — 65.59%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.27%) 0.00% (51.96%)
Return on assets (32.50%) 0.00% (46.06%)
Return on invested capital (118.21%) 0.00% 0.00%

Growth

Metric AVTX BLSM Biotechnology median
Revenue growth (TTM) (92.65%) — 4.59%
EPS growth (last fiscal year) 72.07% (85.30%) 29.88%
Revenue growth, 5-year CAGR (61.19%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AVTX BLSM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.31 5.42 4.86
Net debt to EBITDA 1.36 2.15 1.01

Dividend

Metric AVTX BLSM Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric AVTX BLSM Biotechnology median
Market cap 388.82m 394.45m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack